| 2026-05-08 |
详情>>
业绩披露：
2026年一季报每股收益0.88美元,归母净利润3.09亿美元,同比去年增长5.82%
|
| 2026-05-02 |
详情>>
内部人交易：
Ding Adrian共交易2笔
|
| 2026-04-29 |
详情>>
股本变动：
变动后总股本35100.00万股
变动原因 ▼▲
|
| 2026-04-29 |
财报披露：
美东时间 2026-04-29 盘前发布财报
|
| 2026-04-16 |
股东大会：
将于2026-05-28召开股东大会
会议内容 ▼▲
- 1.To elect the 12 director nominees named in the accompanying proxy statement to serve for a one-year term expiring at the 2027 annual meeting of the Company’s stockholders.
2.To approve and ratify the appointment of KPMG Huazhen LLP and KPMG as the Company’s independent auditors for 2026.
3.To approve, on an advisory basis, the Company’s named executive officer compensation.
4.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s issuance of shares of its common stock or securities convertible into common stock in an amount not to exceed 20% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 28, 2027.
5.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s repurchase of shares of its common stock in an amount not to exceed 10% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 28, 2027.
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2026-02-27 |
详情>>
业绩披露：
2023年年报每股收益1.99美元,归母净利润8.27亿美元,同比去年增长87.10%
|
| 2026-02-27 |
详情>>
业绩披露：
2025年年报每股收益2.52美元,归母净利润9.29亿美元,同比去年增长1.98%
|
| 2025-11-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益2.12美元,归母净利润7.89亿美元,同比去年增长-0.88%
|
| 2025-08-11 |
详情>>
业绩披露：
2025年中报每股收益1.36美元,归母净利润5.07亿美元,同比去年增长1.60%
|
| 2025-05-09 |
详情>>
业绩披露：
2025年一季报每股收益0.78美元,归母净利润2.92亿美元,同比去年增长1.74%
|
| 2025-04-11 |
股东大会：
将于2025-05-23召开股东大会
会议内容 ▼▲
- 1.To elect the 12 director nominees named in the accompanying proxy statement to serve for a one-year term expiring at the 2026 annual meeting of the Company’s stockholders.
2.To approve and ratify the appointment of KPMG Huazhen LLP and KPMG as the Company’s independent auditors for 2025.
3.To approve, on an advisory basis, the Company’s named executive officer compensation.
4.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s issuance of shares of its common stock or securities convertible into common stock in an amount not to exceed 20% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 23, 2026.
5.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s repurchase of shares of its common stock in an amount not to exceed 10% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 23, 2026.
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益1.05美元,归母净利润4.42亿美元,同比去年增长-55.35%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益2.34美元,归母净利润9.11亿美元,同比去年增长10.16%
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益2.04美元,归母净利润7.96亿美元,同比去年增长9.04%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益1.27美元,归母净利润4.99亿美元,同比去年增长2.67%
|
| 2024-05-08 |
详情>>
业绩披露：
2024年一季报每股收益0.72美元,归母净利润2.87亿美元,同比去年增长-0.69%
|
| 2024-04-11 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.To elect the 11 director nominees named in the accompanying proxy statement to serve for a one-year term expiring at the 2025 annual meeting of the Company’s stockholders.
2.To approve and ratify the appointment of KPMG Huazhen LLP and KPMG as the Company’s independent auditors for 2024.
3.To approve, on an advisory basis, the Company’s named executive officer compensation.
4.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s issuance of shares of its common stock or securities convertible into common stock in an amount not to exceed 20% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 23, 2025.
5.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s repurchase of shares of its common stock in an amount not to exceed 10% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 23, 2025.
6.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2023-04-12 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.To elect the nine director nominees named in the accompanying proxy statement to serve for a one-year term expiring at the 2024 annual meeting of the Company’s stockholders.
2.To approve and ratify the appointment of KPMG Huazhen LLP and KPMG as the Company’s independent auditors for 2023.
3.To approve, on an advisory basis, the Company’s named executive officer compensation.
4.To approve, on an advisory basis, the frequency of the advisory vote to approve the Company’s named executive officer compensation.
5.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s issuance of shares of its common stock or securities convertible into common stock in an amount not to exceed 20% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 25, 2024.
6.To approve, pursuant to the rules of the Hong Kong Stock Exchange, the Board’s continuing authority to approve the Company’s repurchase of shares of its common stock in an amount not to exceed 10% of the total number of outstanding shares of common stock of the Company as of the date of the Annual Meeting, effective from date of the Annual Meeting until the earlier of the date the next annual meeting is held or June 25, 2024.
7.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-09-01 |
股东大会：
将于2022-10-11召开股东大会
会议内容 ▼▲
- 1.To approve the Board’s continuing authority to approve the Company’s issuance of shares of its common stock or securities convertible into common stock in an amount not to exceed 20% of the total number of outstanding shares of common stock of the Company as of the date of the Special Meeting, effective from the effective date of the Primary Conversion (the “Primary Conversion Effective Date”) until the earlier of the date the next annual meeting is held or June 26, 2023;
2.To approve the Board’s continuing authority to approve the Company’s repurchase of shares of its common stock in an amount not to exceed 10% of the total number of outstanding shares of common stock of the Company as of the date of the Special Meeting, effective from the Primary Conversion Effective Date until the earlier of the date the next annual meeting is held or June 26, 2023;
3.To approve the Yum China Holdings, Inc. 2022 Long Term Incentive Plan (the “2022 LTIP”).
|
| 2022-04-14 |
股东大会：
将于2022-05-27召开股东大会
会议内容 ▼▲
- 1.To elect the 10 director nominees named in the accompanying proxy statement to serve for a one-year term expiring at the 2023 annual meeting of the Company’s stockholders.
2.To ratify the appointment of KPMG Huazhen LLP as the Company’s independent auditor for 2022.
3.To approve, on an advisory basis, the Company’s named executive officer compensation.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-15 |
股东大会：
将于2021-05-28召开股东大会
会议内容 ▼▲
- 1.Election of the 10 Director Nominees Named in this Proxy Statement to Serve for a One-Year Term
2.Ratification of the Appointment of KPMG Huazhen LLP as the Company’s Independent Auditor for 2021
3.Advisory Vote on Named Executive Officer Compensation
4.Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to allow stockholders holding 25% of the Company’s outstanding shares the right to call special meetings
|
| 2020-03-27 |
股东大会：
将于2020-05-08召开股东大会
会议内容 ▼▲
- 1.To elect the 11 director nominees named in the accompanying proxy statement to serve for a one-year term expiring at the 2021 annual meeting of the Company’s stockholders.
2.To ratify the appointment of KPMG Huazhen LLP as the Company’s independent auditor for 2020.
3.Aapprove, on an advisory basis, the Company’s named executive officer compensation.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2020-02-05 |
除权日：
美东时间 2020-03-03 每股派息0.12美元
|
| 2019-10-29 |
除权日：
美东时间 2019-11-25 每股派息0.12美元
|
| 2019-07-30 |
除权日：
美东时间 2019-08-26 每股派息0.12美元
|
| 2019-04-29 |
除权日：
美东时间 2019-05-24 每股派息0.12美元
|
| 2019-03-29 |
股东大会：
将于2019-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the 12 director nominees named in the accompanying proxy statement to serve for a one-year term expiring at the 2020 annual meeting of the Company’s stockholders.
2.To ratify the appointment of KPMG Huazhen LLP as the Company’s independent auditor for 2019.
3.To approve, on an advisory basis, the Company’s named executive officer compensation.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-01-31 |
除权日：
美东时间 2019-02-27 每股派息0.12美元
|
| 2018-10-30 |
除权日：
美东时间 2018-11-26 每股派息0.12美元
|
| 2018-08-29 |
复牌提示：
2018-08-28 12:34:03 停牌，复牌日期 2018-08-28 12:39:16
|
| 2018-08-01 |
除权日：
美东时间 2018-08-28 每股派息0.10美元
|
| 2018-05-01 |
除权日：
美东时间 2018-05-29 每股派息0.10美元
|
| 2018-03-30 |
股东大会：
将于2018-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the four Class II director nominees named in the accompanying proxy statement to serve until the 2019 annual meeting of the Company’s stockholders.
2.To ratify the appointment of KPMG Huazhen LLP as the Company’s independent auditor for 2018.
3.To approve, on an advisory basis, the Company’s named executive officer compensation.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-02-06 |
除权日：
美东时间 2018-02-27 每股派息0.10美元
|
| 2017-10-04 |
除权日：
美东时间 2017-11-29 每股派息0.10美元
|
| 2017-03-17 |
股东大会：
将于2017-04-28召开股东大会
会议内容 ▼▲
- (1)To elect the three Class I director nominees named in the accompanying proxy statement to serve until the 2019 annual meeting of the Company’s stockholders.
(2)To ratify the appointment of KPMG Huazhen LLP as the Company’s independent auditor for 2017.
(3)To approve, on an advisory basis, the Company’s named executive officer compensation.
(4)To approve, on an advisory basis, the frequency of the advisory vote to approve the Company’s named executive officer compensation.
(5)To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|